Overview

Soft tissue sarcoma is cancer that develops in the tissues that support and connect the body. It can occur in fat, muscle, nerves, tendons, joints, blood vessels, or lymph vessels. Cancer begins when cells grow out of control, and instead of developing into normal cells, they form a tumor or mass (lump). When sarcoma is small, it can go unnoticed or is ignored, since it does not usually cause problems at this stage. As sarcoma grows, it can interfere with the body's normal activities; it can also spread to other places in the body.

This section covers sarcoma of the soft tissue. For information on sarcoma that starts in a bone, read the Cancer.Net Guide to Bone Cancer.

Sarcoma can appear in any part of the body. About 60% occur in the arms or legs, 30% occur in the trunk or abdomen, and 10% occur in the head or neck. Sarcoma is rare, accounting for about 1% of all cancers.

Because there are several different types of soft tissue sarcoma, it is probably best considered as a family of related diseases, rather than a single, specific disease. The specific types of sarcoma are frequently named according to the normal tissue cells they most closely resemble (Table 1), rather than referring to an anatomical site (part of the body) as many other cancer types are named.

Table 1: Types of Sarcoma

Grade is the term a pathologist (a doctor who specializes in interpreting laboratory tests and diagnosing disease) uses to describe how aggressive the sarcoma is likely to be. A low-grade tumor usually stays in one place. A high-grade tumor is more likely to spread to other places, a process known as metastasis.

Experts have identified many types and subtypes of sarcoma. Pathologists are now trying to find new ways to quickly determine a tumor's subtype, as this helps determine treatment. Examination of a tumor's abnormal genetic code may help determine its characteristics and predict which treatments will be most effective. For at least one type of sarcoma, gastrointestinal stromal tumor (GIST), major advances have been made in targeted therapy (drug treatments targeted to specific genetic abnormalities in the sarcoma cell).

Statistics

In 2009, approximately 10,660 people (5,780 males and 4,880 females) will be diagnosed with soft tissue sarcoma in the United States. An estimated 3,820 adults and children (1,960 males and 1,860 females) are expected to die of the disease this year.

The overall five-year relative survival rate (percentage of people who survive at least five years after the cancer is detected, excluding those who die from other diseases), combining all stages and types of sarcoma, is approximately 50%. If the sarcoma is diagnosed at an early stage and hasn’t spread from the original location of the tumor, the five-year survival rate is 83%. The five-year survival rate for cancer that has spread to the lymph nodes is 54%, and the five-year survival rate is 16% if cancer has spread to other parts of the body. However, if the sarcoma is located in an arm or leg, the five-year survival rates are slightly higher for each stage.

Cancer survival statistics should be interpreted with caution. These estimates are based on data from thousands of cases of this type of cancer, but the actual risk for a particular individual may differ. It is not possible to tell a person how long he or she will live with sarcoma. Because the survival statistics are measured in five-year intervals, they may not represent advances made in the treatment or diagnosis of this cancer.

Statistics adapted from the American Cancer Society's publication, Cancer Facts & Figures 2009, and from data from the National Cancer Institute and Memorial Sloan-Kettering Cancer Center.

Find out more about basic cancer terms used in this section.